ASHLEY PRATER: Open Payments
NPI 1548895535 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 46 payments from 16 companies in 2025. Trend: 2023 $380 · 2024 $599 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 13 | $190 |
| Madrigal Pharmaceuticals | 5 | $90 |
| Ardelyx, Inc. | 4 | $78 |
| Janssen Biotech, Inc. | 3 | $63 |
| Endo USA, Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $40 |
Products named: JELMYTO, REZDIFFRA, IBSRELA, TREMFYA, XIAFLEX, ZUSDURI, XIFAXAN, PYLARIFY.
Industry payments across KY — which companies pay providers there.
